Use of trastuzumab for breast cancer: The role of age

Walter Mazzucco; Marta Rossi; Rosanna Cusimano; Matteo Franchi; Martina Bonifazi; Alessandro Mistretta; Francesco Vitale; Walter Ricciardi; Eva Negri; Stefania Boccia; Carlo La Vecchia

Use of trastuzumab for breast cancer: The role of age

Walter Mazzucco, Marta Rossi, Rosanna Cusimano, Matteo Franchi, Martina Bonifazi, Alessandro Mistretta, Francesco Vitale, Walter Ricciardi, Eva Negri, Stefania Boccia, Carlo La Vecchia

Research output: Contribution to journal › Article › peer-review

Abstract

Indication for the use of trastuzumab was given in Italy in 2000 for the treatment of HER-2 metastatic breast cancer and in 2006 for early stage breast cancer. Information on trastuzumab use and on its possible variation with age in Italy is however limited. Using health care administrative databases, we evaluated the prevalence of the use of trastuzumab, and the probability for administration since the first hospitalization for breast cancer in various age groups, in two series of Italian women diagnosed with breast cancer in the Lombardy region (2004-2009) and in the Palermo district. The ratio between trastuzumb users and patients with a hospitalization for breast cancer increased from 2.9% in 2004 up to 17.2% in 2009 in Lombardy. Patients aged

Original language	English
Pages (from-to)	5957-5962
Number of pages	6
Journal	Current Pharmaceutical Design
Volume	20
Issue number	38
Publication status	Published - Jan 1 2014

Keywords

Breast cancer treatment
Early breast cancer
Elderly
Metastatic breast cancer
Trastuzumab

ASJC Scopus subject areas

Drug Discovery
Pharmacology
Medicine(all)

Fingerprint Dive into the research topics of 'Use of trastuzumab for breast cancer: The role of age'. Together they form a unique fingerprint.

Cite this

Use of trastuzumab for breast cancer : The role of age. / Mazzucco, Walter; Rossi, Marta; Cusimano, Rosanna; Franchi, Matteo; Bonifazi, Martina; Mistretta, Alessandro; Vitale, Francesco; Ricciardi, Walter; Negri, Eva; Boccia, Stefania; Vecchia, Carlo La.

In: Current Pharmaceutical Design, Vol. 20, No. 38, 01.01.2014, p. 5957-5962.

Research output: Contribution to journal › Article › peer-review

@article{9bd507859beb4f58ac314fbcc4852a3b,

title = "Use of trastuzumab for breast cancer: The role of age",

abstract = "Indication for the use of trastuzumab was given in Italy in 2000 for the treatment of HER-2 metastatic breast cancer and in 2006 for early stage breast cancer. Information on trastuzumab use and on its possible variation with age in Italy is however limited. Using health care administrative databases, we evaluated the prevalence of the use of trastuzumab, and the probability for administration since the first hospitalization for breast cancer in various age groups, in two series of Italian women diagnosed with breast cancer in the Lombardy region (2004-2009) and in the Palermo district. The ratio between trastuzumb users and patients with a hospitalization for breast cancer increased from 2.9% in 2004 up to 17.2% in 2009 in Lombardy. Patients aged ",

keywords = "Breast cancer treatment, Early breast cancer, Elderly, Metastatic breast cancer, Trastuzumab",

author = "Walter Mazzucco and Marta Rossi and Rosanna Cusimano and Matteo Franchi and Martina Bonifazi and Alessandro Mistretta and Francesco Vitale and Walter Ricciardi and Eva Negri and Stefania Boccia and Vecchia, {Carlo La}",

year = "2014",

month = jan,

day = "1",

language = "English",

volume = "20",

pages = "5957--5962",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "38",

}

TY - JOUR

T1 - Use of trastuzumab for breast cancer

T2 - The role of age

AU - Mazzucco, Walter

AU - Rossi, Marta

AU - Cusimano, Rosanna

AU - Franchi, Matteo

AU - Bonifazi, Martina

AU - Mistretta, Alessandro

AU - Vitale, Francesco

AU - Ricciardi, Walter

AU - Negri, Eva

AU - Boccia, Stefania

AU - Vecchia, Carlo La

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Indication for the use of trastuzumab was given in Italy in 2000 for the treatment of HER-2 metastatic breast cancer and in 2006 for early stage breast cancer. Information on trastuzumab use and on its possible variation with age in Italy is however limited. Using health care administrative databases, we evaluated the prevalence of the use of trastuzumab, and the probability for administration since the first hospitalization for breast cancer in various age groups, in two series of Italian women diagnosed with breast cancer in the Lombardy region (2004-2009) and in the Palermo district. The ratio between trastuzumb users and patients with a hospitalization for breast cancer increased from 2.9% in 2004 up to 17.2% in 2009 in Lombardy. Patients aged

AB - Indication for the use of trastuzumab was given in Italy in 2000 for the treatment of HER-2 metastatic breast cancer and in 2006 for early stage breast cancer. Information on trastuzumab use and on its possible variation with age in Italy is however limited. Using health care administrative databases, we evaluated the prevalence of the use of trastuzumab, and the probability for administration since the first hospitalization for breast cancer in various age groups, in two series of Italian women diagnosed with breast cancer in the Lombardy region (2004-2009) and in the Palermo district. The ratio between trastuzumb users and patients with a hospitalization for breast cancer increased from 2.9% in 2004 up to 17.2% in 2009 in Lombardy. Patients aged

KW - Breast cancer treatment

KW - Early breast cancer

KW - Elderly

KW - Metastatic breast cancer

KW - Trastuzumab

UR - http://www.scopus.com/inward/record.url?scp=84919374924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919374924&partnerID=8YFLogxK

M3 - Article

C2 - 24641226

AN - SCOPUS:84919374924

VL - 20

SP - 5957

EP - 5962

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 38

ER -

Use of trastuzumab for breast cancer: The role of age

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this